By Marilynn Larkin, December 11, 2018 Solriamfetol, an investigational norepinephrine-dopamine reuptake inhibitor, improved excessive daytime sleepiness associated with obstructive sleep apnea (OSA) in a phase 3 trial reported last month in Chest. Click HERE for the full article on MDLinx. This same article also ran in Reuters Health and MD Alert.
By Olivia Muenter, Dec 2018 One of the greatest ironies in my life is that I have trouble falling asleep when I have anxiety and when I can’t sleep, my anxiety usually grows into a panic attack. You might know the feeling, too: Your mind is racing with what ifs and jumping to the worst conclusions. Then your heart […]
by ALEX DIMITRIU, MD, December 2018 Everyone experiences normal ups and downs in their mood, but bipolar disorder – characterized by dramatic shifts in mood, energy and activity levels – can make day-to-day life far more challenging. Fortunately, this psychiatric condition can be effectively controlled with a variety of treatment approaches. Click HERE for the full article on […]
By Kelsey Butler, November 26, 2018 Thanksgiving dinner arguments. Incessant renditions of “Jingle Bells.” New Year’s Eve merriment. The holidays aren’t exactly known for calm and quiet. In fact, this festive time of year can actually wreak havoc on your rest—for a couple of major reasons. Click HERE for the full article on the Saatva […]
